Book Description Liquid pharmaceutical manufacturing is a process of extracting a substance from a substance, such as sugar, water, or other liquids, to create a liquid drug.
Liquid pharmaceuticals can be used as a therapeutic agent, a drug for specific diseases, and/or a drug as a feedstock for industrial processes.
Liquid drug manufacturing is not a new field of research, but it is an important one, as many of the problems that arise from liquid drug manufacturing are not easily understood.
Liquid pharma companies are a new breed of companies that are focused on manufacturing a liquid product, with the aim of increasing their profits and improving their chances of finding a profitable market.
Many of the pharmaceutical companies that seek to manufacture pharmaceuticals are in the process of developing their own liquid pharmaceuticals.
Some of the best examples of these companies are Biogen Idec, Eli Lilly, and Merck.
In the past, liquid pharmaceutical manufacturing was a relatively niche business, but the industry has grown tremendously since the 1990s, as the demand for pharmaceuticals in developing countries has been increasing.
Many countries have made investments in research and development, with pharmaceuticals coming from many different countries and being developed in many different environments.
Many pharmaceutical companies also have large international operations, so it is easy for the pharmaceutical manufacturers to find investors and partners.
Liquid Pharmaceutical Companies: Some of Liquid Pharmaceutical companies include: BioMed Therapeutics (BME) is an innovative biotech company that is focused on developing and commercializing novel drugs and vaccines in the human, animal, and microbial systems.
The company recently made headlines when it announced a collaboration with the United Nations to develop vaccines to treat malaria in Africa.
Biolog Therapeutic Development Company (BTDC) is a biopharmaceutical company that was founded in 2002 by Dr. John B. Moseley, Ph.
D. BTDC is focused primarily on the development and commercialization of novel compounds in biotechnology and pharmaceuticals, including the development of novel biologic therapeutics, including novel pharmaceutical products and vaccines.
Biogen Nuclease (BNX) is the first drug-delivery pipeline company in the United States.
Biogenesis is an established biopharma company focused on the discovery and commercial development of drug delivery pipelines.
BNX is one of the few biopharms that is not affiliated with a single drug company, but rather focuses on developing novel drug delivery technologies and vaccines through its joint venture with Pfizer, Merck, and Pfizer.
BioMolecular Laboratories is a specialty pharmaceutical company focused primarily in the development, manufacture, and delivery of novel therapeutic proteins and peptides for the treatment of multiple diseases and conditions.
BioPharma is a large biopharmacogen company focused in the discovery, manufacture and delivery, of novel therapeutics for human therapeutic proteins, including those targeted for use in cancer, neurological, immunological, cardiovascular, immune, neurodegenerative, and autoimmune disorders.
Biotrauma is a specialized biopharaceutical company focused solely on the clinical development and development of pharmaceuticals for the prevention and treatment of cancer.
Biotechnology Ventures is a subsidiary of Biotech Ventures, which is an investment firm focused on global pharmaceuticals and drug development, including pharmaceuticals that are targeted for human clinical use.
Ciba-Geigy (CGB) is one company in a small group of pharmaceutical companies developing a liquid pharmaceutical product.
CGB was founded by Drs.
David J. Hulsey, Ph., and Mark A. Fung, Ph..
The company is developing its first drug, a novel compound called V-717.
The drug is a new drug targeted for the chronic obstructive pulmonary disease (COPD) category.
BioSciences is a leading biotech company focused principally on the research, development, and commercialisation of new therapeutics in biophysics, chemistry, biochemistry, and biotechnology.
BioRad, an Israeli biotech company, has launched its own liquid product called VX-23.
BioVac is an Israeli biopharsion company focused exclusively on the commercialization and development in the biologic and pharmaceutical industries of novel drug treatments for specific conditions.
Genzyme is a major pharmaceutical company that specializes in the research and discovery of novel pharmaceuticals to treat multiple disease states, including cardiovascular diseases.
The Company’s flagship product, the Zytrak, is a novel drug for the cancer treatment of the pancreas.
GlaxoSmithKline is an international pharma company focused upon the discovery of new therapies and drugs for the management of cardiovascular diseases, including heart attacks, strokes, and other cardiac diseases.
In 2012, GlaxosmithKline was named as one of Forbes’ 100 Most Valuable Companies.
BioSpan is a pharmaceutical company based in China focused on pharmaceutical discovery and development.
BioTherapeutics is a biotech company founded in 2003 and focused on novel drugs in the pharmaceuticals market.
BioMed Research and Development is